Detection of large genomic deletions of FBN1 and confirmation of breakpoints in Marfan syndrome patients with negative results in next-generation sequencing.
4 affiliations
- 1Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
- 2Department of Neurology, Xi'an Central Hospital, Xi'an, China.
- 3Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China. [email protected].
- 4Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China. [email protected].
Abstract
Background
Marfan syndrome (MFS) is an autosomal dominant genetic disorder caused by mutations in the FBN1 gene. Although point mutations in the FBN1 gene are the main pathogenic mutation types for MFS, large genomic deletions and duplications still play a very important role in MFS. Especially for typical MFS patients with negative results in next-generation sequencing, this study aims to study the breakpoints of large genomic structural variations of the FBN1 gene in this type of patients.Methods
Systematic sequencing of FBN1 gene using multiplex ligation dependent probe amplification was performed for 17 unrelated patients with confirmed and/or suspected MFS in China. Sanger sequencing was carried out to confirm the breakpoints.Results
Two novel large deletions encompassing a single exon or multiple exons in the FBN1 gene were characterized in two unrelated patients among the 17 MFS cases. The two deletions (exons 37-38, and 49) exist in the frame of FBN1 gene. The patients with the in-frame deletions of the exons 37-38 and 49 exhibited the typical MFS phenotype. Of which two deletions were proven by Sanger sequencing, and the breakpoints were identified.Conclusions
We characterized two large genomic mutations in FBN1 among MFS patients. The in-frame deletions between exons 37-38 and 49 of FBN1 tended to cause severe MFS clinical phenotypes. Our finding also expands the mutation spectrum of FBN1 large deletions and duplications to highlight the importance of FBN1 screening among the patients with classic Marfan phenotype. At the same time, our detection also highlights the importance of Sanger sequencing validation, which remains the gold standard for sequencing technologies.
Related
- Targeted next-generation sequencing: a promising approach for pathogen and antimicrobial resistance gene detection in urinary tract infections
- Metagenomic next-generation sequencing improves pathogen detection in culture-negative infections: a diagnostic performance study
- Easy detection of CRISPR/Cas9-Induced Insertions, Deletions, and Substitutions in Rice Genes OsMADS26, OsRAC1 and OsNRT1.1b using SYBR Green qPCR and Robust HRM analysis in R software
- Characterisation of the Novel HLA‐DPB1*1979:01 Allele by Next Generation Sequencing
- Identification of the Novel HLA‐B*55:01:37 Allele by Next Generation Sequencing
BibTeX
@article{li2026detection,
title = {{Detection of large genomic deletions of FBN1 and confirmation of breakpoints in Marfan syndrome patients with negative results in next-generation sequencing.}},
author = {Jinjie Li and Quanzeng Zhang and Lin Zhu and Yanjun Diao and Liu Yang and Jiayun Liu},
journal = {BMC medical genomics},
year = {2026},
month = jul,
doi = {10.1186/s12920-026-02421-7},
url = {https://europepmc.org/article/MED/42958517},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Detection of large genomic deletions of FBN1 and confirmation of breakpoints in Marfan syndrome patients with negative results in next-generation sequencing.
AU - Jinjie Li
AU - Quanzeng Zhang
AU - Lin Zhu
AU - Yanjun Diao
AU - Liu Yang
AU - Jiayun Liu
PY - 2026
DA - 2026/07/27
JO - BMC medical genomics
DO - 10.1186/s12920-026-02421-7
UR - https://europepmc.org/article/MED/42958517
AB - Background Marfan syndrome (MFS) is an autosomal dominant genetic disorder caused by mutations in the FBN1 gene. Although point mutations in the FBN1 gene are the main pathogenic mutation types for MFS, large genomic deletions and duplications still play a very important role in MFS. Especially for typical MFS patients with negative results in next-generation sequencing, this study aims to study the breakpoints of large genomic structural variations of the FBN1 gene in this type of patients.Methods Systematic sequencing of FBN1 gene using multiplex ligation dependent probe amplification was performed for 17 unrelated patients with confirmed and/or suspected MFS in China. Sanger sequencing was carried out to confirm the breakpoints.Results Two novel large deletions encompassing a single exon or multiple exons in the FBN1 gene were characterized in two unrelated patients among the 17 MFS cases. The two deletions (exons 37-38, and 49) exist in the frame of FBN1 gene. The patients with the in-frame deletions of the exons 37-38 and 49 exhibited the typical MFS phenotype. Of which two deletions were proven by Sanger sequencing, and the breakpoints were identified.Conclusions We characterized two large genomic mutations in FBN1 among MFS patients. The in-frame deletions between exons 37-38 and 49 of FBN1 tended to cause severe MFS clinical phenotypes. Our finding also expands the mutation spectrum of FBN1 large deletions and duplications to highlight the importance of FBN1 screening among the patients with classic Marfan phenotype. At the same time, our detection also highlights the importance of Sanger sequencing validation, which remains the gold standard for sequencing technologies.
SN - 1755-8794
ER -